Stock in Dr Reddy’s Lab jumps after Finasteride tablets’ launch in US

Stock in Dr Reddy’s Laboratories gained as much as 2.7 per cent to Rs 1,886.80 a share on the Bombay Stock Exchange (BSE) on Thursday, after the drug firm announced the launch of its generic Finasteride tablets in the American market. Dr Reddy’s Laboratories announced that it had launched Finasteride tablets, for treating male pattern hair loss, in the strength of 1 mg in the U. S. market on January 2 after regulators approved its abbreviated new drug application (ANDA) with 180-day of marketing exclusivity. read more

Stock in Dr Reddy’s Laboratories gained as much as 2.7 per cent to Rs 1,886.80 a share on the Bombay Stock Exchange (BSE) on Thursday, after the drug firm announced the launch of its generic Finasteride tablets in the American market. Dr Reddy’s Laboratories announced that it had launched Finasteride tablets, for treating male pattern hair loss, in the strength of 1 mg in the U. S. market on January 2 after regulators approved its abbreviated new drug application (ANDA) with 180-day of marketing exclusivity. read more

[via Stock Watch – Stock Specific News]

Follow us @enterpriseheat – lists / @sectorheat

Leave a Reply

Your email address will not be published. Required fields are marked *